D
IDEAYA Biosciences, Inc. IDYA
$34.34 $0.651.93% NASDAQ
Recommendation
Prev Close
$33.69
Volume
1,520,599
Avg Vol (90D)
1,145,072
Market Cap
$2.95B
Dividend & Yield
--
52-Week Range
$13.45 - $36.55
P/E (TTM)
--
EPS (TTM)
-$1.85
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
IDEAYA Biosciences (IDYA, $33.69) Moving Average Convergence Divergence (MACD) Histogram turned negative on December 2, 2025
12/3/2025 - Tickeron - Stocks
IDEAYA Biosciences, Inc. (IDYA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
12/2/2025 - Seeking Alpha: Transcripts
IDEAYA Biosciences, Inc. (IDYA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
12/2/2025 - SeekingAlpha
IDEAYA Biosciences (NASDAQ:IDYA) Hits New 52-Week High - Time to Buy?
12/2/2025 - MarketBeat
IDEAYA Biosciences (IDYA) Receives a Buy from Mizuho Securities
12/2/2025 - TipRanks Financial Blog
FDA IND Clearance for IDE034 Could Be a Game Changer for IDEAYA Biosciences (IDYA)
12/1/2025 - Simply Wall St
Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and IDEAYA Biosciences (IDYA)
12/1/2025 - TipRanks Financial Blog
IDEAYA Biosciences Announces IND Clearance for IDE034, a Potential First-in-Class Bispecific ...
12/1/2025 - GuruFocus
Ideaya Biosciences (IDYA) Advances with FDA Green Light for IDE034 Trial
12/1/2025 - GuruFocus
Ideaya Biosciences announces FDA clearance of IDE034 IND application
12/1/2025 - The Fly
IDEAYA Biosciences Announces IND Clearance for IDE034, a Potential First-in-Class Bispecific B7H3/PTK7 TOP1 ADC Targeting Multiple Solid Tumor Types
12/1/2025 - PR Newswire
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
11/28/2025 - GuruFocus
IDEAYA Biosciences (IDYA) Awards Stock Options to New Employee
11/28/2025 - GuruFocus
Ideaya Biosciences announces inducement grants under Nasdaq listing rule
11/28/2025 - The Fly
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
11/28/2025 - PR Newswire
Assessing IDEAYA Biosciences (IDYA) Valuation Following Recent Share Price Momentum
11/28/2025 - Simply Wall St
Foresite Capital Management VI LLC Takes Position in IDEAYA Biosciences, Inc. $IDYA
11/26/2025 - MarketBeat
Ideaya Biosciences: Primed For Success - Major Eye Cancer Catalyst Weeks Away
11/25/2025 - SeekingAlpha
Ideaya Biosciences: Primed For Success - Major Eye Cancer Catalyst Weeks Away
11/25/2025 - Seeking Alpha - Long Ideas
IDEAYA Biosciences (NASDAQ:IDYA) Hits New 52-Week High - Here's Why
11/25/2025 - MarketBeat
IDEAYA Biosciences (NASDAQ:IDYA) Now Covered by Analysts at Truist Financial
11/25/2025 - MarketBeat
Creative Planning Boosts Stake in IDEAYA Biosciences, Inc. $IDYA
11/25/2025 - MarketBeat
Truist Securities Initiates Coverage on IDEAYA Biosciences (IDYA) with a "Buy" Rating ...
11/24/2025 - GuruFocus
Ideaya Biosciences initiated with bullish view at Truist, here's why
11/24/2025 - The Fly
IDEAYA Biosciences to Participate in Upcoming December 2025 Investor Relations Events
11/24/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
$214.83M
EBITDA (TTM)
-$206.33M
EBIT (TTM)
-$208.88M
Net Income (TTM)
-$160.74M
Balance Sheet
Total Assets (Q)
$1.19B
Total Debt (Q)
$27.25M
Total Liabilities (Q)
$93.10M
Book Value Per Share (Q)
$12.46
Cash Flow
Cash from Operations (TTM)
-$102.26M
Cash from Investing (TTM)
-$29.61M
Cash from Financing (TTM)
$30.40M
Net Change in Cash (TTM)
-$101.46M
Filings
Filing Date
Tuesday, November 4, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 16 and 20 (est)
Price History
Loading...
Beta
1.12
7-Day Total Return
1.03%
30-Day Total Return
17.60%
60-Day Total Return
38.80%
90-Day Total Return
37.25%
Year to Date Total Return
36.49%
1-Year Total Return
28.81%
2-Year Total Return
5.95%
3-Year Total Return
93.25%
5-Year Total Return
140.31%
52-week Low
Apr 09, 2025 - $13.45
52-week High
Nov 26, 2025 - $36.55
Valuation
Market Cap
$2.95B - Mid Cap
Enterprise Value
$1.84B
Price/Sales (TTM)
14.07
Price/Book (Q)
2.70
Dividends and Shares
Shares Outstanding
89.69
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.ideayabio.com
Phone Number
650 443 6209
Address
5000 Shoreline Court
South San Francisco, CA 94080
Country
United States
Year Founded
2015
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
IDEAYA Biosciences, Inc., a precision medicine oncology company, discovers and develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States... more
NASDAQ 12/03/2025 4:00PM Eastern Quotes delayed